Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States.

Human pluripotent stem cells (hPSCs) represent very promising resources for cell-based regenerative medicine. It is essential to determine the biological implications of some fundamental physiological processes (such as glycogen metabolism) in these stem cells. In this report, we employ electron, im...

Full description

Bibliographic Details
Main Authors: Richard J Chen, Guofeng Zhang, Susan H Garfield, Yi-Jun Shi, Kevin G Chen, Pamela G Robey, Richard D Leapman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4643957?pdf=render
_version_ 1811281749804580864
author Richard J Chen
Guofeng Zhang
Susan H Garfield
Yi-Jun Shi
Kevin G Chen
Pamela G Robey
Richard D Leapman
author_facet Richard J Chen
Guofeng Zhang
Susan H Garfield
Yi-Jun Shi
Kevin G Chen
Pamela G Robey
Richard D Leapman
author_sort Richard J Chen
collection DOAJ
description Human pluripotent stem cells (hPSCs) represent very promising resources for cell-based regenerative medicine. It is essential to determine the biological implications of some fundamental physiological processes (such as glycogen metabolism) in these stem cells. In this report, we employ electron, immunofluorescence microscopy, and biochemical methods to study glycogen synthesis in hPSCs. Our results indicate that there is a high level of glycogen synthesis (0.28 to 0.62 μg/μg proteins) in undifferentiated human embryonic stem cells (hESCs) compared with the glycogen levels (0 to 0.25 μg/μg proteins) reported in human cancer cell lines. Moreover, we found that glycogen synthesis was regulated by bone morphogenetic protein 4 (BMP-4) and the glycogen synthase kinase 3 (GSK-3) pathway. Our observation of glycogen bodies and sustained expression of the pluripotent factor Oct-4 mediated by the potent GSK-3 inhibitor CHIR-99021 reveals an altered pluripotent state in hPSC culture. We further confirmed glycogen variations under different naïve pluripotent cell growth conditions based on the addition of the GSK-3 inhibitor BIO. Our data suggest that primed hPSCs treated with naïve growth conditions acquire altered pluripotent states, similar to those naïve-like hPSCs, with increased glycogen synthesis. Furthermore, we found that suppression of phosphorylated glycogen synthase was an underlying mechanism responsible for altered glycogen synthesis. Thus, our novel findings regarding the dynamic changes in glycogen metabolism provide new markers to assess the energetic and various pluripotent states in hPSCs. The components of glycogen metabolic pathways offer new assays to delineate previously unrecognized properties of hPSCs under different growth conditions.
first_indexed 2024-04-13T01:39:13Z
format Article
id doaj.art-e9074ddc6fb94cb59548317c753f2712
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T01:39:13Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e9074ddc6fb94cb59548317c753f27122022-12-22T03:08:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011011e014255410.1371/journal.pone.0142554Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States.Richard J ChenGuofeng ZhangSusan H GarfieldYi-Jun ShiKevin G ChenPamela G RobeyRichard D LeapmanHuman pluripotent stem cells (hPSCs) represent very promising resources for cell-based regenerative medicine. It is essential to determine the biological implications of some fundamental physiological processes (such as glycogen metabolism) in these stem cells. In this report, we employ electron, immunofluorescence microscopy, and biochemical methods to study glycogen synthesis in hPSCs. Our results indicate that there is a high level of glycogen synthesis (0.28 to 0.62 μg/μg proteins) in undifferentiated human embryonic stem cells (hESCs) compared with the glycogen levels (0 to 0.25 μg/μg proteins) reported in human cancer cell lines. Moreover, we found that glycogen synthesis was regulated by bone morphogenetic protein 4 (BMP-4) and the glycogen synthase kinase 3 (GSK-3) pathway. Our observation of glycogen bodies and sustained expression of the pluripotent factor Oct-4 mediated by the potent GSK-3 inhibitor CHIR-99021 reveals an altered pluripotent state in hPSC culture. We further confirmed glycogen variations under different naïve pluripotent cell growth conditions based on the addition of the GSK-3 inhibitor BIO. Our data suggest that primed hPSCs treated with naïve growth conditions acquire altered pluripotent states, similar to those naïve-like hPSCs, with increased glycogen synthesis. Furthermore, we found that suppression of phosphorylated glycogen synthase was an underlying mechanism responsible for altered glycogen synthesis. Thus, our novel findings regarding the dynamic changes in glycogen metabolism provide new markers to assess the energetic and various pluripotent states in hPSCs. The components of glycogen metabolic pathways offer new assays to delineate previously unrecognized properties of hPSCs under different growth conditions.http://europepmc.org/articles/PMC4643957?pdf=render
spellingShingle Richard J Chen
Guofeng Zhang
Susan H Garfield
Yi-Jun Shi
Kevin G Chen
Pamela G Robey
Richard D Leapman
Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States.
PLoS ONE
title Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States.
title_full Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States.
title_fullStr Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States.
title_full_unstemmed Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States.
title_short Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States.
title_sort variations in glycogen synthesis in human pluripotent stem cells with altered pluripotent states
url http://europepmc.org/articles/PMC4643957?pdf=render
work_keys_str_mv AT richardjchen variationsinglycogensynthesisinhumanpluripotentstemcellswithalteredpluripotentstates
AT guofengzhang variationsinglycogensynthesisinhumanpluripotentstemcellswithalteredpluripotentstates
AT susanhgarfield variationsinglycogensynthesisinhumanpluripotentstemcellswithalteredpluripotentstates
AT yijunshi variationsinglycogensynthesisinhumanpluripotentstemcellswithalteredpluripotentstates
AT kevingchen variationsinglycogensynthesisinhumanpluripotentstemcellswithalteredpluripotentstates
AT pamelagrobey variationsinglycogensynthesisinhumanpluripotentstemcellswithalteredpluripotentstates
AT richarddleapman variationsinglycogensynthesisinhumanpluripotentstemcellswithalteredpluripotentstates